Performance testing system DTG 100i

qualificationcommunicationtemperature

Overview
The DTGi series disintegration testers from Copley are designed for pharmaceutical R&D and QC environments. Suitable for a wide range of tablets and capsules (e.g. plain-coated, delayed‑release, gelatine capsules). The series meets requirements in Ph. Eur., USP and associated pharmacopoeias and offers scalable configurations from one to four test stations.

Key features (summary)

• Ph. Eur. 2.9.1 and USP <701> and <2040> compliant
• Integrated precision temperature control with PT100 probe
• Passcode-protected single-point electronic temperature calibration; calibration history stored
• Intuitive icon-based touchscreen control
• Available in 1–4 station configurations; optional independent station control (DTG 200i-IS)
• Extensive reporting and export options (RS-232, USB A, USB B)
• Options for automation and remote control

Common product details and user-centric features

• Quick-release baskets for fast loading, unloading and cleaning
• Basket racks automatically lower/raise to/from test media at test start/end
• Robust metal enclosure with corrosion-protective coating
• Independent digital heater/circulator for stable temperature and reduced vibration
• Removable leak‑proof water bath with drain tap and maximum fill indicator
• PT100 temperature probe monitors bath and media temperature
• Adjustable stroke frequency for accelerated or high-sensitivity testing

DTG 100i
Catalogue Number: 1231
Pharmacopoeial Compliance: Ph. Eur. 2.9.1; USP <701> and <2040>
Number of Test Stations: 1
Tablet Capacity: Up to 6
Independent Station Control: No
Unit Dimensions (w x d x h): 450 x 473 x 657 mm

DTG 200i
Catalogue Number: 1232
Pharmacopoeial Compliance: Ph. Eur. 2.9.1; USP <701> and <2040>
Number of Test Stations: 2
Tablet Capacity: Up to 12
Independent Station Control: No
Unit Dimensions (w x d x h): 450 x 473 x 657 mm

DTG 300i
Catalogue Number: 1233
Pharmacopoeial Compliance: Ph. Eur. 2.9.1; USP <701> and <2040>
Number of Test Stations: 3
Tablet Capacity: Up to 18
Independent Station Control: No
Unit Dimensions (w x d x h): 700 x 473 x 657 mm

DTG 400i
Catalogue Number: 1234
Pharmacopoeial Compliance: Ph. Eur. 2.9.1; USP <701> and <2040>
Number of Test Stations: 4
Tablet Capacity: Up to 24
Independent Station Control: No
Unit Dimensions (w x d x h): 700 x 473 x 657 mm

DTG 200i-IS (Independent Station option)
Catalogue Number: 1238
Pharmacopoeial Compliance: Ph. Eur. 2.9.1; USP <701> and <2040>
Number of Test Stations: 2
Tablet Capacity: Up to 12
Independent Station Control: Yes (each station independently controlled)
Unit Dimensions (w x d x h): 515 x 473 x 657 mm

Compliance & Maintenance

• Certificate of compliance to Ph. Eur./USP provided as standard
• IQ/OQ/PQ documentation packages and commissioning toolkits available
• Passcode-protected single-point electronic temperature calibration with stored calibration records
• Latest calibration data available to print/export

Technical specifications

• Compliances: Ph. Eur. 2.9.1; USP <701> and <2040>
• Test-station configurations: 1, 2, 3 or 4 stations
• Independent station control: available (DTG 200i-IS)
• Tablet capacity: up to 6, 12, 18 or 24 tablets depending on model
• Temperature control: integrated digital heater/circulator with PT100 probe; passcode single-point calibration; calibration history stored
• Bath: removable leak‑proof water bath with drain tap and maximum fill line indicator
• User interface: intuitive touchscreen with icon-based menu
• Data outputs: RS-232, USB A, USB B
• Construction: robust metal case with corrosion protection
• Accessories: special basket racks (large tablets, covered baskets for gelatine capsules), hygiene treatments, label printer and automation options